Fort Myers, FL, July 29, 2011 --(PR.com
)-- 21st Century Oncology has introduced hyperthermia to use in conjunction with radiation therapy for treatment of progressive or recurrent tumors with the addition of the BSD-500 Hyperthermia System (BSD-500), the only system of its kind in the Southwest Florida area.
The purchase of the BSD-500 by 21st Century Oncology significantly increases the number of patients who will have access to hyperthermia treatment. "Thanks to dedicated scientists and clinicians, we now have good clinical data on hyperthermia treatment and an excellent delivery device to offer our patients," said Alan Brown, Jr., MD, Radiation Oncologist. "The addition of hyperthermia to the services here provides patients a greater opportunity for innovative treatment options close to home. It also adds another weapon to our arsenal in the battle with cancer."
Daniel Dosoretz, MD, founder and CEO of 21st Century Oncology stated, "We have used hyperthermia in the past. This technology is a quantum leap to provide better care to our patients and our network of doctors here in Southwest Florida and soon throughout our other locations."
About 21st Century Oncology
21st Century Oncology, headquartered in Fort Myers, Fla., is a leading provider of radiation therapy centers and operates 98 freestanding and hospital-based centers in the U.S. 21st Century Oncology centers provide sophisticated technology, a high standard of quality patient care and service with a full spectrum of advanced treatments to cancer patients. As part of the company’s central tenets, 21st Century Oncology's physicians are trained by some of the most prestigious and recognized medical training centers and universities in the world and their senior radiation oncologists are nationally recognized for excellence and leadership in the field of radiation oncology. Ongoing clinical research is leading toward more effective cancer treatments, and 21st Century Oncology is committed to participating in that research.
About the BSD-500 Hyperthermia System
The BSD-500 Hyperthermia System is used to deliver therapeutic heating (hyperthermia) using either non-invasive (external) hyperthermia, which is delivered using antennas placed over the tumor, or interstitial hyperthermia, which is delivered using antennas that are inserted into the tumor, or a combination of both. The BSD-500 has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), which is the standard FDA approval required to market Class III medical devices in the United States, for the use of hyperthermia alone or in conjunction with radiation therapy for the treatment of certain tumors.
Press contact: Sherri Kubesh, 239-839-6015, firstname.lastname@example.org